MDLN Earnings Date: Nov 4, 2026 (Estimated) — Medline Inc.
NASDAQ · Healthcare · Medical Instruments & Supplies
Updated
When is MDLN's next earnings date?
Medline Inc. (MDLN) is expected to report earnings on Wednesday, November 4, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.34 on revenue of $7.72B.
How did MDLN do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), Medline Inc. posted EPS of $0.50 versus the $0.35 estimate, a beat of 56.3%. Revenue was $7.68B against a $7.52B estimate. The stock's 1-day post-earnings move was -12.8%.
How much does MDLN stock move after earnings?
MDLN beat EPS estimates in 2 of its last 3 reported quarters. Over the last 3 reports the stock moved an average of 7.9% (up or down) in the day after earnings.
About Medline Inc.
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | 0.35 | 0.50 | +56.25% | $7.68B | ✅ Beat | -12.79% | -16.65% | -13.65% |
| 2026-05-06 | Q1 2026 | 0.29 | 0.33 | +13.79% | $7.40B | ✅ Beat | -7.30% | -14.94% | -23.98% |
| 2026-02-25 | Q4 2025 | 0.24 | -0.01 | -104.17% | $7.79B | ❌ Miss | -3.62% | -11.20% | -14.64% |
Showing last 3 quarters.
Revenue by segment & region
By region
Q2 FY26 · $7.68B total
| Segment | Share | Revenue | YoY |
|---|---|---|---|
| UNITED STATES | 93.1% | $7.15B | — |
| Non-US | 6.9% | $533.0M | — |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.